Skip to main content

Sandy El Bitar

Assistant Professor of Medicine
Medicine, Hematology

Selected Publications


Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms.

Journal Article Clin Adv Hematol Oncol · March 2024 The treatment landscape for BCR/ABL-negative myeloproliferative neoplasms (MPNs), driven by JAK2, CALR, and MPL mutations, has evolved significantly over the last decade. Recent regulatory approvals in polycythemia vera (PV) include the JAK inhibitor ruxol ... Link to item Cite